Home / Drugs / Antihemophilic Factor (Recombinant), Fc Fusion Protein

Antihemophilic Factor (Recombinant), Fc Fusion Protein

FDA Drug Profile — ELOCTATE

Drug Details

Generic Name
Antihemophilic Factor (Recombinant), Fc Fusion Protein
Brand Names
ELOCTATE
Application Number
BLA125487
Sponsor
Bioverativ Therapeutics Inc.
NDC Codes
10
Dosage Forms
KIT
Routes
INTRAVENOUS
Active Ingredients
N/A